News

Generative AI is projected to grow faster in health care than any other sector—and leading medtech and pharmaceutical manufacturers are rapidly evolving from experimenting with GenAI to transforming operations. In a recent BCG survey, approximately 25% of biopharma companies and some 10% of medtech companies reported that AI accounted for cost reductions and revenue increases of at least 5%, along with significant improvements in speed and agility. But a significant portion of health care manufa